X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs AUROBINDO PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD AUROBINDO PHARMA MERCK LTD/
AUROBINDO PHARMA
 
P/E (TTM) x 26.8 18.2 146.8% View Chart
P/BV x 3.0 4.5 67.2% View Chart
Dividend Yield % 0.9 0.4 269.7%  

Financials

 MERCK LTD   AUROBINDO PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
AUROBINDO PHARMA
Mar-17
MERCK LTD/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,060895 118.4%   
Low Rs623622 100.2%   
Sales per share (Unadj.) Rs632.4254.6 248.4%  
Earnings per share (Unadj.) Rs45.739.3 116.4%  
Cash flow per share (Unadj.) Rs62.346.6 133.8%  
Dividends per share (Unadj.) Rs11.002.50 440.0%  
Dividend yield (eoy) %1.30.3 396.6%  
Book value per share (Unadj.) Rs388.8160.0 243.1%  
Shares outstanding (eoy) m16.60585.88 2.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.33.0 44.7%   
Avg P/E ratio x18.419.3 95.3%  
P/CF ratio (eoy) x13.516.3 82.9%  
Price / Book Value ratio x2.24.7 45.6%  
Dividend payout %24.16.4 378.0%   
Avg Mkt Cap Rs m13,969444,390 3.1%   
No. of employees `0001.614.0 11.3%   
Total wages/salary Rs m1,48717,678 8.4%   
Avg. sales/employee Rs Th6,631.910,667.8 62.2%   
Avg. wages/employee Rs Th939.21,264.3 74.3%   
Avg. net profit/employee Rs Th479.41,645.8 29.1%   
INCOME DATA
Net Sales Rs m10,498149,157 7.0%  
Other income Rs m2421,159 20.9%   
Total revenues Rs m10,741150,316 7.1%   
Gross profit Rs m1,13534,343 3.3%  
Depreciation Rs m2764,276 6.4%   
Interest Rs m0667 0.0%   
Profit before tax Rs m1,10230,558 3.6%   
Minority Interest Rs m050 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3437,597 4.5%   
Profit after tax Rs m75923,012 3.3%  
Gross profit margin %10.823.0 47.0%  
Effective tax rate %31.124.9 125.3%   
Net profit margin %7.215.4 46.9%  
BALANCE SHEET DATA
Current assets Rs m6,41092,062 7.0%   
Current liabilities Rs m8,82866,223 13.3%   
Net working cap to sales %-23.017.3 -133.0%  
Current ratio x0.71.4 52.2%  
Inventory Days Days58106 54.4%  
Debtors Days Days3868 56.7%  
Net fixed assets Rs m1,40662,919 2.2%   
Share capital Rs m166586 28.3%   
"Free" reserves Rs m6,28693,133 6.7%   
Net worth Rs m6,45593,719 6.9%   
Long term debt Rs m01,814 0.0%   
Total assets Rs m8,828162,494 5.4%  
Interest coverage xNM46.8-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.20.9 129.5%   
Return on assets %8.614.6 59.0%  
Return on equity %11.824.6 47.9%  
Return on capital %17.132.7 52.2%  
Exports to sales %8.30-   
Imports to sales %21.00-   
Exports (fob) Rs m869NA-   
Imports (cif) Rs m2,209NA-   
Fx inflow Rs m95975,838 1.3%   
Fx outflow Rs m2,61230,224 8.6%   
Net fx Rs m-1,65345,613 -3.6%   
CASH FLOW
From Operations Rs m1,07032,786 3.3%  
From Investments Rs m-750-17,870 4.2%  
From Financial Activity Rs m-150-19,153 0.8%  
Net Cashflow Rs m171-4,239 -4.0%  

Share Holding

Indian Promoters % 0.0 54.1 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 8.0 228.9%  
FIIs % 1.0 27.7 3.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 10.2 285.3%  
Shareholders   28,591 69,601 41.1%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   FULFORD INDIA  SUVEN LIFE  IPCA LABS  WOCKHARDT LTD.  VENUS REMEDIES  

Compare MERCK LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Pharma Stocks Witness Buying(01:30 pm)

After opening the day on a positive note, the Indian share markets have continued the momentum and are currently trading comfortably in green.

Related Views on News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

'Buy and Hold Forever' Not The Best Investing Style After All(The 5 Minute Wrapup)

Nov 9, 2017

Even Buffett didn't always Buy and Hold forever. A look at Berkshire's 1992 and 2017 portfolios will tell you the story...

Of Falling Real Estate Prices, Dr Arvind Panagariya and the Art of Continuing to Suck Up(Vivek Kaul's Diary)

Nov 13, 2017

Dr Panagariya claims real estate prices have fallen 25 per cent post demonetisation; the official data doesn't show anything like that.

Your Last Chance to Trade ONLY the Best Stocks(Daily Profit Hunter)

Nov 11, 2017

Techno-Funda opportunities are knocking on your door. Are you ready to receive them?

You're Lucky You Missed Out on that IPO...(Smart Contrarian)

Nov 8, 2017

Here's how to profit from upcoming IPOs.

Why I am the Biggest India Equity Bull on Planet Earth!(The Honest Truth)

Nov 16, 2017

If you have a dream, dream big...about the level of BSE 30 index in 2050!

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Nov 21, 2017 01:29 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE MERCK LTD WITH

MARKET STATS